Hexadecyl Dihydrogen Phosphate

Hexadecyl Dihydrogen Phosphate

SCHEMBL63165

CCCCCCCCCCCCCCCCOP(=O)(O)O.OCCNCCO

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PTGIRfolP

The experimentally established mechanism targets of Hexadecyl Dihydrogen Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 12/20 0.72
LPAR2 Q9HBW0 9/20 0.72
LPAR1 Q92633 7/20 0.72
LPAR5 Q9H1C0 1/20 0.47
S1PR2 O95136 5/20 0.47
S1PR4 O95977 5/20 0.47
S1PR1 P21453 5/20 0.47
S1PR3 Q99500 5/20 0.47
S1PR5 Q9H228 1/20 0.47
ENPP2 Q13822 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid Monododecyl Ester SCHEMBL1882508 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5S1PR2
Diethanolamine SCHEMBL27863592 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5S1PR2
Diethanolamine SCHEMBL11424123 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5S1PR2
Phosphoric Acid Monotetradecyl Ester SCHEMBL28891633 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5S1PR2
Diethanolamine SCHEMBL31042095 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5S1PR2
Hexadecyl Dihydrogen Phosphate SCHEMBL9365294 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5S1PR2
Hexadecyl Dihydrogen Phosphate SCHEMBL28236129 1.00 LPAR3 (0.72) LPAR3LPAR2LPAR1LPAR5S1PR2
Phosphoric Acid Monododecyl Ester SCHEMBL29070679 0.98 LPAR3 (0.70) LPAR3LPAR2LPAR1LPAR5S1PR2
Diethanolamine SCHEMBL3471215 0.91 LPAR3 (0.72) LPAR3LPAR2LPAR1ENPP2
Hexadecyl Dihydrogen Phosphate SCHEMBL29103357 0.91 LPAR3 (0.60) LPAR3LPAR2LPAR1LPAR5S1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3376 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12576108-B2 Compositions comprising hyper harmonized hydroxyl modified fullerene substances FIELDPOINT (CYPRUS) LIMITED (CY) 2026-03-17 US claimed
US-20250277207-A1 One or Multiple-Steps Extraction of Nucleic Acids and other Biomolecules using a Cloudy Precipitated Solution CHHALLIYIL PRADHEEP (US) 2025-09-04 US claimed
US-20250049771-A1 METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS ARCUTIS BIOTHERAPEUTICS, INC. (US) 2025-02-13 US claimed
WO-2025021320-A1 RETINOL CONTAINING DAY CREAM THE BOOTS COMPANY PLC (GB) 2025-01-30 WO claimed
US-20240382504-A1 TREATMENT OF SKIN CONDITIONS USING HIGH KRAFFT TEMPERATURE ANIONIC SURFACTANTS ARCUTIS BIOTHERAPEUTICS, INC. (US) 2024-11-21 US claimed
US-20240350378-A1 DEODORANT COSMETIC PRODUCT JOBAN BEAUTY, INC. (US) 2024-10-24 US claimed
US-12042487-B2 Method for reducing side effects from administration of phosphodiesterase-4 inhibitors ARCUTIS BIOTHERAPEUTICS, INC. (US) 2024-07-23 US claimed
EP-3765088-B1 TRANSDERMAL AND/OR DERMAL DELIVERY OF LIPOPHILIC ACTIVE AGENTS POVIVA CORP (US) 2024-03-20 EP claimed
CN-113365599-B Composition for stabilizing vitamin C derivatives by gel structure 株式会社爱茉莉太平洋 2024-03-15 CN claimed
US-20240024300-A1 METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS ARCUTIS BIOTHERAPEUTICS, INC. (US) 2024-01-25 US claimed
US-5116604-A Sunscreen compositions containing novel neopentanoate esters BERNEL CHEMICAL CO. (US) 1992-05-26 US claimed
EP-0443007-A1 AN EXTERNAL ANALGESIC LOTION AND METHOD OF MAKING. IVY JEFFERY W (US) 1991-08-28 EP claimed
US-5013726-A External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion AU PHARMACEUTICALS, INC. 1991-05-07 US claimed
WO-1991004010-A1 AN EXTERNAL ANALGESIC LOTION AND METHOD OF MAKING IVY JEFFERY W (US) 1991-04-04 WO claimed
EP-0404331-A2 Cosmetic composition UNILEVER PLC (GB) 1990-12-27 EP claimed
US-4970216-A CONTAINING FREE RADICAL INHIBITOR OR DEACTIVATOR RICHARDSON VICKS, INC. (US) 1990-11-13 US claimed
US-4939179-A Cosmetic emulsions with hydrocarbon thickening agents CHESEBROUGH-POND'S INC. (US) 1990-07-03 US claimed
US-4847267-A 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID AND ETHOXYQUIN CHARLES OF THE RITZ GROUP LTD. (US) 1989-07-11 US claimed
EP-0238302-A1 Skin treatment composition Richardson-Vicks, Inc. (US) 1987-09-23 EP claimed
US-4481186-A SKIN CONDITIONERS CHARLES OF THE RITZ GROUP LTD. (US) 1984-11-06 US claimed